Qilu Pharmaceuticals looks for innovative ideas at research center in Boston

Larry Cai is based in Boston, heading up the New England business development arm of Qilu, a major pharmaceutical company in China. The Boston Qilu Innovation Center offers startups and researchers everything from lab space to investment to find faster ways to put innovative treatments on the market for oncology, liver disease and other unmet needs. With lots of experience working with Chinese regulatory agencies, Qilu can speed the drug development process for products that will be released to the China market.

Join us for valuable insights on cross-border investment and partnering opportunities at China Showcase during Biotech Showcase.